Lactobacillus rhamnosus and L. plantarum Combination Treatment Ameliorated Colitis Symptoms in a Mouse Model by Altering Intestinal Microbial Composition and Suppressing Inflammatory Response
Molecular Nutrition & Food Research · 2023
DOI: 10.1002/mnfr.202200340 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2023. Verfasst von Yangyang Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Agricultural Microbiology and College of Life Science and Technology, Huazhong Agricultural University, Wuhan, 430070, China. Hauptthemen laut MEDLINE: Lacticaseibacillus rhamnosus, Colitis, Lactiplantibacillus plantarum. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hubei Province.
Abstract (Originalsprache)
Scope Changes in composition of intestinal microbes may disrupt the balance of their interaction with a susceptible host, resulting in development of inflammatory bowel disease (IBD). Methods and results The study applied in combination two Lactobacillus strains ( L. rhamnosus BY‐02, L. plantarum BY‐05) (“LS treatment”), previously isolates from feces of healthy human infants, in a mouse model of dextran sodium sulfate (DSS)‐induced colitis, and evaluates their ameliorative effect and its possible mechanism. LS treatment suppresses weight loss and colon shortening, and reduces disease activity index in the mice. It also has several additional beneficial effects: i) maintains goblet cell numbers and ameliorates intestinal barrier damage in colonic tissue; ii) alters intestinal microbial composition close to normal by increasing abundances of Muribaculaceae , Akkermansia , Clostridia , Oscillospiraceae , and Lachnospiraceae , and decreasing abundance of Escherichia‐Shigella ; iii) increases content of short‐chain fatty acids; iv) reduces content of pro‐inflammatory lipopolysaccharides; v) suppresses overactivation of TLR4/NF‐κB inflammatory signaling pathway. Conclusion Combination treatment with two Lactobacillus strains strongly ameliorates colitis symptoms in the mouse model by favorably altering intestinal microbial composition and suppressing inflammatory response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Agricultural Microbiology and College of Life Science and Technology, Huazhong Agricultural University, Wuhan, 430070, China.
ORCID-Profile: Yangyang Liu
Förderung
- Natural Science Foundation of Hubei Province
Zitieren
APA
Liu, Y., Zhang, H., Xie, A., Sun, J., Yang, H., Li, J., Li, Y., Chen, F., Mei, Y., & Liang, Y. (2023). Lactobacillus rhamnosus and L. plantarum Combination Treatment Ameliorated Colitis Symptoms in a Mouse Model by Altering Intestinal Microbial Composition and Suppressing Inflammatory Response. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.202200340
Vancouver
Liu Y, Zhang H, Xie A, Sun J, Yang H, Li J, et al. Lactobacillus rhamnosus and L. plantarum Combination Treatment Ameliorated Colitis Symptoms in a Mouse Model by Altering Intestinal Microbial Composition and Suppressing Inflammatory Response. Molecular Nutrition & Food Research. 2023. doi:10.1002/mnfr.202200340
BibTeX
@article{Liu2023,
author = {Liu, Yangyang and Zhang, Heng and Xie, Aowen and Sun, Jingzhou and Yang, Huiqing and Li, Jinshan and Li, Yingjun and Chen, Fei and Mei, Yuxia and Liang, Yunxiang},
title = {Lactobacillus rhamnosus and L. plantarum Combination Treatment Ameliorated Colitis Symptoms in a Mouse Model by Altering Intestinal Microbial Composition and Suppressing Inflammatory Response},
journal = {Molecular Nutrition & Food Research},
year = {2023},
doi = {10.1002/mnfr.202200340}
}
EUVIMED